Authors: Videtic, GMM Fung, K Tomiak, AT Stitt, LW Dar, AR Truong, PT Yu, EW Vincent, MD Kocha, WI

Citation: Gmm. Videtic et al., Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control, LUNG CANC, 33(2-3), 2001, pp. 249-258

Authors: Kirkbride, P Bezjak, A Pater, J Zee, B Palmer, MJ Wong, R Cross, P Gulavita, S Blood, P Sun, A Dundas, G Ganguly, PK Lim, J Chowdhury, AD Kumar, SE Dar, AR

Citation: P. Kirkbride et al., Dexamethasone for the prophylaxis of radiation-induced emesis: A National Cancer Institute of Canada Clinical Trials Group phase III study, J CL ONCOL, 18(9), 2000, pp. 1960-1966

Authors: Sause, W Kolesar, P Taylor, S Johnson, D Livingston, R Komaki, R Emami, B Curran, W Byhardt, R Dar, AR Turrisi, A

Citation: W. Sause et al., Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group, CHEST, 117(2), 2000, pp. 358-364

Authors: Movsas, B Scott, C Sause, W Byhardt, R Komaki, R Cox, J Johnson, D Lawton, C Dar, AR Wasserman, T Roach, M Lee, JS Andras, E

Citation: B. Movsas et al., The benefit of treatment intensification is age and histology-dependent inpatients with locally advanced nonsmall cell lung cancer (NSCLC): A quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies, INT J RAD O, 45(5), 1999, pp. 1143-1149